KEY FEATURES
Full Name | Cyclin Dependent Kinase 2 |
---|---|
Synonym | CDKN2; p33(CDK2); Cell division protein kinase 2; p33 protein kinase |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.15-10ng/mL |
Sensitivity | 0.06ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human CDK2 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CDK2. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CDK2 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CDK2, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CDK2. You can calculate the concentration of Human CDK2 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CDK2 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.54 | 1.6 | 3.96 | 0.54 | 1.67 | 3.6 |
Standard deviation | 0.03 | 0.07 | 0.16 | 0.03 | 0.07 | 0.18 |
CV(%) | 5.8 | 4.15 | 4.03 | 5.64 | 4.38 | 5.09 |
RECOVERY
The recovery of Human CDK2 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 85-101 | 92 |
EDTA plasma (n=8) | 90-107 | 98 |
Cell culture media (n=8) | 90-105 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CDK2 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CDK2 ELISA Kits
CDKN1A ELISA Kit | publications with CDK2 and CDKN1A |
CDKN1B ELISA Kit | publications with CDK2 and CDKN1B |
PCNA ELISA Kit | publications with CDK2 and PCNA |
CDC25A ELISA Kit | publications with CDK2 and CDC25A |
CDK7 ELISA Kit | publications with CDK2 and CDK7 |
SKP2 ELISA Kit | publications with CDK2 and SKP2 |
CCNA2 ELISA Kit | publications with CDK2 and CCNA2 |
CDC6 ELISA Kit | publications with CDK2 and CDC6 |
CCNE1 ELISA Kit | publications with CDK2 and CCNE1 |
RBL1 ELISA Kit | publications with CDK2 and RBL1 |
Pathways associated with CDK2 ELISA Kit
APC/C-mediated Degradation Of Cell Cycle Proteins Pathway | APC/C-mediated Degradation Of Cell Cycle Proteins Pathway |
Activation Of ATR In Response To Replication Stress Pathway | Activation Of ATR In Response To Replication Stress Pathway |
Activation Of The Pre-replicative Complex Pathway | Activation Of The Pre-replicative Complex Pathway |
B Cell Receptor Signaling Pathway | B Cell Receptor Signaling Pathway |
BARD1 Signaling Events Pathway | BARD1 Signaling Events Pathway |
CDK-mediated Phosphorylation And Removal Of Cdc6 Pathway | CDK-mediated Phosphorylation And Removal Of Cdc6 Pathway |
Cell Cycle Pathway | Cell Cycle Pathway |
Cell Cycle Checkpoints Pathway | Cell Cycle Checkpoints Pathway |
Cell Cycle, Mitotic Pathway | Cell Cycle, Mitotic Pathway |
Diseases associated with CDK2 ELISA Kit
Neoplasms | publications with CDK2 and Neoplasms |
Breast Neoplasms | publications with CDK2 and Breast Neoplasms |
Adenocarcinoma | publications with CDK2 and Adenocarcinoma |
Neoplasms, Experimental | publications with CDK2 and Neoplasms, Experimental |
Drug Toxicity | publications with CDK2 and Drug Toxicity |
Liver Diseases | publications with CDK2 and Liver Diseases |
Liver Neoplasms | publications with CDK2 and Liver Neoplasms |
Prostatic Neoplasms | publications with CDK2 and Prostatic Neoplasms |
Lung Neoplasms | publications with CDK2 and Lung Neoplasms |
Carcinoma, Hepatocellular | publications with CDK2 and Carcinoma, Hepatocellular |
Organs/Tissues associated with CDK2 ELISA Kit
Lymph Node | publications with CDK2 and Lymph Node |
Uterus | publications with CDK2 and Uterus |